Literature DB >> 11786497

Mu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cells.

A Alt1, M J Clark, J H Woods, J R Traynor.   

Abstract

1. There is evidence for interactions between mu and delta opioid systems both in vitro and in vivo. This work examines the hypothesis that interaction between these two receptors can occur intracellularly at the level of G protein in human neuroblastoma SH-SY5Y cells. 2. The [(35)S]GTP gamma S binding assay was used to measure G protein activation following agonist occupation of opioid receptors. The agonists DAMGO (EC(50), 45 nM) and SNC80 (EC(50), 32 nM) were found to be completely selective for stimulation of [(35)S]-GTP gamma S binding through mu and delta opioid receptors respectively. Maximal stimulation of [(35)S]-GTP gamma S binding produced by SNC80 was 57% of that seen with DAMGO. When combined with a maximally effective concentration of DAMGO, SNC80 caused no additional [(35)S]-GTP gamma S binding. This effect was also seen when measured at the level of adenylyl cyclase. 3. Receptor activation increased the dissociation of pre-bound [(35)S]-GTP gamma S. In addition, the delta agonist SNC80 promoted the dissociation of [(35)S]-GTP gamma S from G proteins initially labelled using the mu agonist DAMGO. Conversely, DAMGO promoted the dissociation of [(35)S]-GTP gamma S from G proteins initially labelled using SNC80. 4. Tolerance to DAMGO and SNC80 in membranes from cells exposed to agonist for 18 h was homologous and there was no evidence for alteration in G protein activity. 5. The findings support the hypothesis that mu- and delta-opioid receptors share a common G protein pool, possibly through a close organization of the two receptors and G protein at the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11786497      PMCID: PMC1573101          DOI: 10.1038/sj.bjp.0704430

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  47 in total

1.  Persistent membrane association of activated and depalmitoylated G protein alpha subunits.

Authors:  C Huang; J A Duncan; A G Gilman; S M Mumby
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

2.  Theoretical effects of single and multiple transducer receptor coupling proteins on estimates of the relative potency of agonists.

Authors:  T P Kenakin; P H Morgan
Journal:  Mol Pharmacol       Date:  1989-02       Impact factor: 4.436

3.  Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo.

Authors:  R J Sheldon; L Nunan; F Porreca
Journal:  J Pharmacol Exp Ther       Date:  1989-05       Impact factor: 4.030

4.  Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for mu opioid receptors.

Authors:  J T Pelton; W Kazmierski; K Gulya; H I Yamamura; V J Hruby
Journal:  J Med Chem       Date:  1986-11       Impact factor: 7.446

5.  Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells.

Authors:  S M Kazmi; R K Mishra
Journal:  Mol Pharmacol       Date:  1987-07       Impact factor: 4.436

6.  Modulation of mu-mediated antinociception by delta agonists in the mouse: selective potentiation of morphine and normorphine by [D-Pen2,D-Pen5]enkephalin.

Authors:  J S Heyman; J L Vaught; H I Mosberg; R C Haaseth; F Porreca
Journal:  Eur J Pharmacol       Date:  1989-06-08       Impact factor: 4.432

7.  Effects of Mg2+ and the beta gamma-subunit complex on the interactions of guanine nucleotides with G proteins.

Authors:  T Higashijima; K M Ferguson; P C Sternweis; M D Smigel; A G Gilman
Journal:  J Biol Chem       Date:  1987-01-15       Impact factor: 5.157

8.  Modulation of mu-mediated antinociception by delta agonists: characterization with antagonists.

Authors:  J S Heyman; Q Jiang; R B Rothman; H I Mosberg; F Porreca
Journal:  Eur J Pharmacol       Date:  1989-10-04       Impact factor: 4.432

9.  Isolation of two proteins with high affinity for guanine nucleotides from membranes of bovine brain.

Authors:  P C Sternweis; J D Robishaw
Journal:  J Biol Chem       Date:  1984-11-25       Impact factor: 5.157

10.  Mu and delta receptors: their role in analgesia in the differential effects of opioid peptides on analgesia.

Authors:  J L Vaught; R B Rothman; T C Westfall
Journal:  Life Sci       Date:  1982-04-26       Impact factor: 5.037

View more
  8 in total

1.  Gi/o-coupled receptors compete for signaling to adenylyl cyclase in SH-SY5Y cells and reduce opioid-mediated cAMP overshoot.

Authors:  Erica S Levitt; Lauren C Purington; John R Traynor
Journal:  Mol Pharmacol       Date:  2010-11-22       Impact factor: 4.436

2.  Opioid-induced down-regulation of RGS4: role of ubiquitination and implications for receptor cross-talk.

Authors:  Qin Wang; John R Traynor
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

3.  Mechanisms of G protein activation via the D2 dopamine receptor: evidence for persistent receptor/G protein interaction after agonist stimulation.

Authors:  K Quirk; D J Roberts; P G Strange
Journal:  Br J Pharmacol       Date:  2007-03-12       Impact factor: 8.739

Review 4.  The delta opioid receptor tool box.

Authors:  Ana Vicente-Sanchez; Laura Segura; Amynah A Pradhan
Journal:  Neuroscience       Date:  2016-06-24       Impact factor: 3.590

5.  Collision coupling, crosstalk, and compartmentalization in G-protein coupled receptor systems: can a single model explain disparate results?

Authors:  Christopher J Brinkerhoff; John R Traynor; Jennifer J Linderman
Journal:  J Theor Biol       Date:  2008-08-08       Impact factor: 2.691

6.  GTPgammaS incorporation in the rat brain: a study on mu-opioid receptors and CXCR4.

Authors:  Silvia Burbassi; Vincent J Aloyo; Kenny J Simansky; Olimpia Meucci
Journal:  J Neuroimmune Pharmacol       Date:  2007-10-25       Impact factor: 4.147

7.  Differential modulation of mu- and delta-opioid receptor agonists by endogenous RGS4 protein in SH-SY5Y cells.

Authors:  Qin Wang; Lee-Yuan Liu-Chen; John R Traynor
Journal:  J Biol Chem       Date:  2009-05-05       Impact factor: 5.157

8.  Modulation of μ-opioid receptor signaling by RGS19 in SH-SY5Y cells.

Authors:  Qin Wang; John R Traynor
Journal:  Mol Pharmacol       Date:  2012-11-29       Impact factor: 4.436

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.